93 related articles for article (PubMed ID: 9781666)
1. The promoter of human p22/PACAP response gene 1 (PRG1) contains functional binding sites for the p53 tumor suppressor and for NFkappaB.
Schäfer H; Diebel J; Arlt A; Trauzold A; Schmidt WE
FEBS Lett; 1998 Oct; 436(2):139-43. PubMed ID: 9781666
[TBL] [Abstract][Full Text] [Related]
2. The proliferation-associated early response gene p22/PRG1 is a novel p53 target gene.
Schäfer H; Trauzold A; Sebens T; Deppert W; Fölsch UR; Schmidt WE
Oncogene; 1998 May; 16(19):2479-87. PubMed ID: 9627114
[TBL] [Abstract][Full Text] [Related]
3. p22/PACAP response gene 1 (PRG1): a putative target gene for the tumor suppressor p53.
Schäfer H; Trauzold A; Sebens T; Deppert W; Fölsch UR; Schmidt WE
Ann N Y Acad Sci; 1998 Dec; 865():27-36. PubMed ID: 9927993
[TBL] [Abstract][Full Text] [Related]
4. p22/PRG1: a novel early response gene in pancreatic cancer cells regulated by p53 and NF kappa B.
Schmidt WE; Arlt A; Trauzold A; Schäfer H
Ann N Y Acad Sci; 1999 Jun; 880():147-56. PubMed ID: 10415858
[No Abstract] [Full Text] [Related]
5. The putative apoptosis inhibitor IEX-1L is a mutant nonspliced variant of p22(PRG1/IEX-1) and is not expressed in vivo.
Schäfer H; Arlt A; Trauzold A; Hünermann-Jansen A; Schmidt WE
Biochem Biophys Res Commun; 1999 Aug; 262(1):139-45. PubMed ID: 10448082
[TBL] [Abstract][Full Text] [Related]
6. Genomic organization, promoter cloning, and chromosomal localization of the Dif-2 gene.
Pietzsch A; Büchler C; Schmitz G
Biochem Biophys Res Commun; 1998 Apr; 245(3):651-7. PubMed ID: 9588170
[TBL] [Abstract][Full Text] [Related]
7. Synergistic and opposing regulation of the stress-responsive gene IEX-1 by p53, c-Myc, and multiple NF-kappaB/rel complexes.
Huang YH; Wu JY; Zhang Y; Wu MX
Oncogene; 2002 Oct; 21(44):6819-28. PubMed ID: 12360408
[TBL] [Abstract][Full Text] [Related]
8. Repression of glucocorticoid receptor transactivation and DNA binding of a glucocorticoid response element within the serum/glucocorticoid-inducible protein kinase (sgk) gene promoter by the p53 tumor suppressor protein.
Maiyar AC; Phu PT; Huang AJ; Firestone GL
Mol Endocrinol; 1997 Mar; 11(3):312-29. PubMed ID: 9058378
[TBL] [Abstract][Full Text] [Related]
9. Human PACAP response gene 1 (p22/PRG1): proliferation-associated expression in pancreatic carcinoma cells.
Schäfer H; Lettau P; Trauzold A; Banasch M; Schmidt WE
Pancreas; 1999 May; 18(4):378-84. PubMed ID: 10231843
[TBL] [Abstract][Full Text] [Related]
10. PRG1: a novel early-response gene transcriptionally induced by pituitary adenylate cyclase activating polypeptide in a pancreatic carcinoma cell line.
Schäfer H; Trauzold A; Siegel EG; Fölsch UR; Schmidt WE
Cancer Res; 1996 Jun; 56(11):2641-8. PubMed ID: 8653710
[TBL] [Abstract][Full Text] [Related]
11. [Interaction of p53 with p53 response element like binding sequence at upstream of hepatitis B virus enhancer I].
Qu JH; Zhu MH; Lin J; Ni CR; Li FM; Zhu Z; Yu GZ
Ai Zheng; 2004 May; 23(5):502-7. PubMed ID: 15142443
[TBL] [Abstract][Full Text] [Related]
12. Expression of the NF-kappa B target gene IEX-1 (p22/PRG1) does not prevent cell death but instead triggers apoptosis in Hela cells.
Arlt A; Grobe O; Sieke A; Kruse ML; Fölsch UR; Schmidt WE; Schäfer H
Oncogene; 2001 Jan; 20(1):69-76. PubMed ID: 11244505
[TBL] [Abstract][Full Text] [Related]
13. Hypermethylation of growth arrest DNA damage-inducible gene 45 beta promoter in human hepatocellular carcinoma.
Qiu W; Zhou B; Zou H; Liu X; Chu PG; Lopez R; Shih J; Chung C; Yen Y
Am J Pathol; 2004 Nov; 165(5):1689-99. PubMed ID: 15509538
[TBL] [Abstract][Full Text] [Related]
14. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene.
Miyashita T; Reed JC
Cell; 1995 Jan; 80(2):293-9. PubMed ID: 7834749
[TBL] [Abstract][Full Text] [Related]
15. Cloning and characterization of the promoter region of human focal adhesion kinase gene: nuclear factor kappa B and p53 binding sites.
Golubovskaya V; Kaur A; Cance W
Biochim Biophys Acta; 2004 May; 1678(2-3):111-25. PubMed ID: 15157737
[TBL] [Abstract][Full Text] [Related]
16. Modulation of interleukin-6-induced plasma protein secretion in hepatoma cells by p53 species.
Wang L; Rayanade RJ; Garcia D; Patel K; Pan H; Sehgal PB
J Biol Chem; 1995 Sep; 270(39):23159-65. PubMed ID: 7559462
[TBL] [Abstract][Full Text] [Related]
17. The core promoter region of the P-glycoprotein gene is sufficient to confer differential responsiveness to wild-type and mutant p53.
Zastawny RL; Salvino R; Chen J; Benchimol S; Ling V
Oncogene; 1993 Jun; 8(6):1529-35. PubMed ID: 8502478
[TBL] [Abstract][Full Text] [Related]
18. P53-dependent suppression of the human calcyclin gene (S100A6): the role of Sp1 and of NFkappaB.
Króliczak W; Pietrzak M; Puzianowska-Kuznicka M
Acta Biochim Pol; 2008; 55(3):559-70. PubMed ID: 18714402
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional activation of the human proliferating-cell nuclear antigen promoter by p53.
Morris GF; Bischoff JR; Mathews MB
Proc Natl Acad Sci U S A; 1996 Jan; 93(2):895-9. PubMed ID: 8570655
[TBL] [Abstract][Full Text] [Related]
20. Induction of Mdr1b expression by tumor necrosis factor-alpha in rat liver cells is independent of p53 but requires NF-kappaB signaling.
Ros JE; Schuetz JD; Geuken M; Streetz K; Moshage H; Kuipers F; Manns MP; Jansen PL; Trautwein C; Müller M
Hepatology; 2001 Jun; 33(6):1425-31. PubMed ID: 11391531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
